中文 | English
Return
Total: 274 , 1/28
Show Home Prev Next End page: GO
Author:(Ke-Wu XU)

1.Preparation and evaluation of oridonin derivatives

Xu WU ; Feng ZHAO ; Ke LIU

Chinese Traditional and Herbal Drugs 1994;0(03):-

2.Predictive value of preoperative 18F-FDG PET/CT imaging combined with coagulation parameters for recurrence in patients with early cervical cancer

Ke WU ; Chen XU ; Hongzan SUN

Chinese Journal of Nuclear Medicine and Molecular Imaging 2021;41(6):334-340

3.Effect of fluoride concentration on the corrosion behavior of cobalt-chromium alloy fabricated by two different technology processes.

Qiuxia YANG ; Ying YANG ; Han XU ; Di WU ; Ke GUO

West China Journal of Stomatology 2016;34(1):47-53

4.Percentage of primary open angle glaucoma in retinal vein occlusion patients

Ke, XU ; Lingling, WU ; Zhizhong, MA ; Yuling, LIU ; Fang, QIAN

Chinese Journal of Experimental Ophthalmology 2016;34(6):552-557

5.Progress in a relevant role of sirtuins in age-related cataract

Ying, SUN ; Shu-Bin, WU ; Ke, XU ; Zhi-Jian, LI

International Eye Science 2015;(4):618-620

6.The clinical observation of Qianlietai tablets on curing the chronic-abacterial-prostatitis

Jun-Yan WU ; Suiwen YE ; Ke-Wei XU ;

Chinese Journal of Primary Medicine and Pharmacy 2006;0(09):-

7.Characteristics of HIV/AIDS cases with non-marital or non-commercial heterosexual transmission in Hangzhou

ZHAO Gang ; ZHANG Xingliang ; CHEN Junfang ; XU Ke ; WU Hong

Journal of Preventive Medicine 2021;33(12):1209-1214

8.Quality of life and its influencing factors among people living with HIV/AIDS in Hangzhou City

ZHANG Xingliang ; CHEN Junfang ; XU Ke ; WU Hong ; HUANG Sichao

Journal of Preventive Medicine 2022;34(1):27-32

9.Factors affecting immune reconstitution in HIV/AIDS patients after antiretroviral therapy

WU Hong ; XU Ke ; ZHANG Xingliang ; LI Xiting ; CHENG Wei

Journal of Preventive Medicine 2024;36(4):277-282

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 274 , 1/28 Show Home Prev Next End page: GO